The "P-Shot" (a trademarked name for platelet-rich plasma, or PRP, injected into the penis) is marketed at med spas and men's clinics as a regenerative, drug-free fix for erectile dysfunction — using a concentrate spun from your own blood to supposedly trigger tissue repair. It's sold alongside shockwave therapy as part of the same "restorative medicine" pitch, but the evidence behind it is noticeably thinner — smaller trials, fewer independent research groups, and reviewers who keep arriving at the same cautious verdict: promising, not proven.
What's Your Prostate Risk Score?
Take ManCore's free 6-question risk assessment. Get your personal risk score, see which supplements are most relevant to your profile, and get a clear action plan — in under 2 minutes.
What PRP Is Supposed to Do
Platelet-rich plasma is made by drawing a small amount of blood, spinning it in a centrifuge, and concentrating the platelet-rich layer — which contains growth factors involved in tissue healing. For ED, this concentrate is injected directly into the penile tissue (intracavernosal injection), on the theory that those growth factors stimulate new blood vessel formation and nerve repair in tissue affected by vasculogenic ED. It's an extension of PRP's established use in orthopedics (tendon and joint injuries), applied to a different tissue with a much thinner evidence base behind it.
The Actual Trial Evidence: Smaller and Newer Than Shockwave
The first double-blind, randomized, placebo-controlled trial of PRP for ED wasn't published until 2021. It was small — 60 men with mild-to-moderate ED, 30 getting real PRP and 30 getting a placebo injection, from a single center in Greece. At 6 months, 69% of the PRP group achieved a clinically meaningful improvement in erectile function versus 27% of the placebo group — a real, statistically significant difference, with no adverse events reported [2]. That's a genuinely positive result. The catch is what it rests on: one trial, one center, 60 total patients, and the authors' own stated limitation that the findings "lack external validity due to single-center design" [2].
- •A 2021 systematic review covering the earliest PRP-for-ED research (10 human studies at the time) concluded the approach "may be promising, but no recommendation can be made because of scarce evidence" [1]
- •A 2025 meta-analysis pooling 7 randomized trials and 660 patients found PRP improved erectile function scores at 12 and 24 weeks, but not at 4 weeks — and explicitly stated the findings "still required large-scale clinical trials for verification" [5]
- •Several of the trials behind these reviews come from the same small number of research groups rather than a broad, independent base of replication — a narrower evidence base than shockwave therapy's, which has a 2026 Cochrane review behind it
What the Most Recent Reviews Actually Conclude
A 2023 systematic review by the same research group that ran the original placebo-controlled trial reviewed 23 total studies (preclinical and clinical) and concluded there is an "urgent need for high-quality studies with long-term follow-up," adding that "standardization of research protocols, especially on the quality of PRP preparation, is also needed" [3] — notable, coming from researchers with a direct stake in the therapy's reputation. A separate, independent 2024 systematic review from a different research group (Denmark/Italy) reached a similarly measured conclusion after screening 164 articles down to 17 eligible studies: PRP showed "small to moderate benefits" but the overall literature was "limited and difficult to interpret due to variations in protocols and methodological drawbacks," with only 4 of the included studies being randomized controlled trials at all [4].
Every review of this evidence, including the ones written by researchers who've published positive trials, lands on the same caveat: the protocols aren't standardized and the trials are too small and too few to call this proven. If you're weighing whether to pay out of pocket for it, a documented baseline of your own erectile function — not a clinic's testimonial — is the only way to judge whether it actually did anything for you.
What This Means If You're Considering the P-Shot
- •PRP for ED has no FDA approval for this specific use — it's an off-label application of a blood-product procedure, not a cleared device-specific treatment, similar in that respect to how shockwave therapy is marketed
- •Cost is entirely out of pocket, and "P-Shot" branded clinics often charge premium prices for what is, materially, a standard PRP preparation process used elsewhere in medicine for a fraction of the cost
- •The best-supported case so far is mild-to-moderate vasculogenic ED — the same population where shockwave therapy also shows its best results, which is part of why clinics increasingly bundle the two together
- •The safety profile looks genuinely good across the available trials — no serious adverse events have been reported — so the real question is value for money and realistic expectations, not physical risk
- •If a clinic presents this as a settled, guaranteed-results treatment rather than an emerging therapy with real but limited evidence, that's a sign to ask more questions, not fewer
Related Reading
Shockwave Therapy for ED: What the Evidence Actually Shows
The other "restorative medicine" ED treatment often bundled with PRP — its evidence base is larger but still genuinely contested.
Erectile Dysfunction Treatment: Every Option Explained (2026)
How PRP and shockwave therapy compare to established first-line ED treatments like PDE5 inhibitors.
What Is Erectile Dysfunction? Causes, Symptoms & Complete Overview
Background on vasculogenic ED, the specific form PRP's evidence base is best suited to.
Supplements for Circulatory Support
Snap Supplements Nitric Oxide Booster + Prostate Health
Supports healthy circulation — a lower-cost complement to discuss with your doctor while you weigh pricier procedural options like PRP.
Male Optimization Formula
General men's health formula worth discussing with your doctor as part of a broader plan; not a substitute for evaluating the underlying cause of ED.
Affiliate disclosure: ManCore earns a small commission on purchases made through these links at no extra cost to you.
Frequently Asked Questions
Does the P-Shot actually work for ED?
The best single piece of evidence — a 2021 placebo-controlled trial — found a real, statistically significant improvement in erectile function at 6 months. But it was one small trial at one center. Systematic reviews since then, including a 2025 meta-analysis of 7 trials, consistently describe the overall evidence as promising but not yet proven, citing a need for larger, more standardized studies [1][2][5].
Is the P-Shot FDA-approved?
No. PRP injection for ED is an off-label use of a blood-product preparation process, not an FDA-cleared treatment for erectile dysfunction specifically. This is a similar regulatory position to shockwave therapy.
How much does the P-Shot cost?
It's paid entirely out of pocket, and "P-Shot" branded clinics often charge a premium over the cost of a standard PRP preparation, which is a well-established, inexpensive procedure used in other areas of medicine.
Is PRP for ED safe?
The safety data across available trials is reassuring — no serious adverse events have been reported in the randomized trials reviewed to date. The open question is how much benefit you're actually paying for, not physical safety [1][3][4].
Is the P-Shot or shockwave therapy better supported by evidence?
Shockwave therapy has a larger and more mature evidence base, including a 2026 Cochrane review. PRP's evidence is newer, smaller in scale, and concentrated among fewer research groups. Both are considered emerging therapies rather than established first-line treatments.
The Bottom Line
The P-Shot rests on real but early evidence — one genuinely positive placebo-controlled trial, and systematic reviews that keep landing on the same conclusion: promising, under-standardized, and in need of larger studies before anyone should call it proven. That's a thinner evidence base than shockwave therapy, not a stronger one, whatever the marketing at a given clinic implies. The safety profile looks good, which lowers the risk of trying it — but go in knowing you're an early adopter of a therapy still being figured out, not a patient getting an established, guideline-backed treatment.